PHARMAC - Latest News [Page 29]
New treatment funded for HIV/AIDS
Tuesday, 1 June 2004, 2:16 pm | PHARMAC
A PHARMAC funding decision is to give people with advanced HIV/AIDS access to a new fully-funded treatment. More >>
NZ plays its role in war against resistance
Wednesday, 26 May 2004, 11:55 am | PHARMAC
New Zealand is continuing to do its bit in the international fight against bacterial resistance, with the launch of PHARMAC’s Wise Use of Antibiotics Campaign today. More >>
Fewer New Zealanders taking antibiotics
Wednesday, 26 May 2004, 9:18 am | PHARMAC
Research shows that fewer New Zealanders are likely to reach for antibiotics to treat colds and flu, compared to numbers seen four years ago. More >>
Asthma drug doses make positive move
Friday, 14 May 2004, 9:54 am | PHARMAC
Prescribing data shows there has been a healthy change in the use of asthma preventers, in line with the aims of PHARMAC’s Responsible Use of Inhaled Corticosteroids campaign. More >>
Continued access to two cholesterol drugs
Tuesday, 11 May 2004, 4:12 pm | PHARMAC
PHARMAC is responding to the advice of expert clinicians in providing people with continued fully subsidised access two cholesterol-lowering statins drugs. More >>
New fully funded treatment for alcohol addiction
Monday, 10 May 2004, 12:09 am | PHARMAC
Government drug-funding agency PHARMAC has agreed to provide subsidy for naltrexone (ReVia) from 1 June 2004. More >>
PHARMAC commits further $39 mn to NZers’ health
Tuesday, 10 February 2004, 3:11 pm | PHARMAC
More than 14,000 New Zealanders are set to benefit from recent decisions to invest more in medicines by Government drug-funding agency PHARMAC. More >>
Green Prescriptions an effective health investment
Thursday, 5 February 2004, 4:14 pm | PHARMAC
Green Prescriptions, a SPARC (Sport & Recreation New Zealand) and General Practice programme that helps doctors encourage people to become more physically active, is highly cost effective according to new research released today. More >>
New treatment for Hepatitis C patients
Wednesday, 4 February 2004, 12:55 am | PHARMAC
A new and more effective combination treatment for people with Hepatitis C is to be funded by Government drug-buying agency PHARMAC. More >>
Tender expected to deliver further health savings
Tuesday, 6 January 2004, 6:22 pm | PHARMAC
Further savings and ensured supply of medicines are expected to result from the 2003-04 PHARMAC tender, which has been issued to pharmaceutical suppliers. More >>
Agreement offers relief children with arthritis
Monday, 22 December 2003, 9:04 am | PHARMAC
Children with arthritis will have access to a new fully-subsidised treatment from 1 February 2004. More >>
New Anti-Depressant Drug Funded
Wednesday, 10 December 2003, 2:39 pm | PHARMAC
A new treatment for depression will be funded from 1 January 2004 following an agreement between PHARMAC and pharmaceutical company Wyeth (NZ) Ltd. More >>
Wellington Professor appointed to chair PTAC
Tuesday, 2 December 2003, 2:34 pm | PHARMAC
Wellington-based physician and clinical pharmacologist Professor Carl Burgess has been appointed to chair the Pharmacology and Therapeutics Advisory Committee (PTAC). More >>
PHARMAC welcomes new Board appointment
Tuesday, 2 December 2003, 2:32 pm | PHARMAC
PHARMAC Board chairman Richard Waddel has welcomed the appointment of Tauranga management consultant Adrienne von Tunzelmann to the Board of the Government drug-funding agency. More >>
Big jump in statins use but many not accessing
Wednesday, 26 November 2003, 4:31 pm | PHARMAC
More people are getting the benefits of cholesterol-lowering statin drugs but prescribing figures could be higher yet, says PHARMAC Medical Director Dr Peter Moodie. More >>
PHARMAC predicts continuing HRT prescribing drop
Wednesday, 26 November 2003, 2:25 pm | PHARMAC
Even fewer New Zealand women are likely to opt for Hormone Replacement Therapy (HRT) despite the already large drop-off in use, predicts drug funding agency PHARMAC. More >>
Medicine use continues to rise
Wednesday, 26 November 2003, 11:06 am | PHARMAC
New Zealanders are taking more medicine than ever before, according to figures just released by drug funding agency PHARMAC. More >>
PHARMAC AstraZeneca agree to continued drug supply
Friday, 21 November 2003, 3:00 pm | PHARMAC
People will be able to continue taking all dosage strengths of the calcium channel blocker drug felodipine. More >>
Pharmac Disappointed At Multinational’s Decision
Friday, 14 November 2003, 3:25 pm | PHARMAC
PHARMAC will be doing all it can to ensure New Zealanders continue to have access to the heart drug felodipine, following the surprise decision by multinational company AstraZeneca to suddenly cease supplying it to New Zealand. More >>
More Medicines To Be Funded In 2003-04
Monday, 29 September 2003, 8:52 am | PHARMAC
More people will have access to subsidised medicines through an agreement to raise the pharmaceutical budget to $566 million in the 2003-04 financial year. More >>
